LPL Financial’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

LPL Financial’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,065	Closed	-$7K	–	3503
2019 Q4	$7K	Buy	+1,065	New	+$7.84K	﹤0.01%	3339
2018 Q2	–	Sell	-1,558	Closed	-$45K	–	3319
2018 Q1	$45K	Buy	+1,558	New	+$45.6K	﹤0.01%	3124
2017 Q2	–	Sell	-1,400	Closed	-$9K	–	3037
2017 Q1	$9K	Buy	+1,400	New	+$10.1K	﹤0.01%	2693

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LPL Financial's AVEO Position: Q1 2020 in Review

LPL Financial sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2020, closing a stake of 1,065 shares — an estimated $7K sold.

LPL Financial first reported a position in AVEO in Q1 2017 and held it in 3 quarters. The position peaked at $45K in Q1 2018. 35 funds tracked by Wall St. Rank hold AVEO as of Q1 2020.

LPL Financial reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
LPL Financial sold 1,065 AVEO Pharmaceuticals, Inc. shares in Q1 2020, an estimated $7K.
LPL Financial first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2017 and held it in 3 quarters.
LPL Financial's AVEO Pharmaceuticals, Inc. position peaked at $45K in Q1 2018.
35 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2020.

Based on LPL Financial's 13F filing for Q1 2020, filed 14 May 2020.